128 related articles for article (PubMed ID: 6377287)
1. Hyperkalaemia in diabetes mellitus--potential hazards of coexisting hyporeninaemic hypoaldosteronism.
Large DM; Carr PH; Laing I; Davies M
Postgrad Med J; 1984 May; 60(703):370-3. PubMed ID: 6377287
[TBL] [Abstract][Full Text] [Related]
2. Persistent hyperkalaemia.
Xu B; Murray M
Aust Fam Physician; 2009 May; 38(5):307-9. PubMed ID: 19458800
[TBL] [Abstract][Full Text] [Related]
3. Treating proteinuria in a diabetic patient despite hyperkalaemia due to hyporeninaemic hypoaldosteronism.
van Nieuwkoop C; Ijpelaar DH; Bolk JH
Neth J Med; 2007 Feb; 65(2):75-7. PubMed ID: 17379933
[TBL] [Abstract][Full Text] [Related]
4. Hyperkalaemia secondary to hypo-aldosteronism. A report of 2 cases differentiating hyperreninaemic from hyporeninaemic hypo-aldosteronism.
Diamond TH; Huddle KR; Dubb A
S Afr Med J; 1987 Jan; 71(1):40-2. PubMed ID: 3541255
[TBL] [Abstract][Full Text] [Related]
5. Hyporeninemic hypoaldosteronism. An overlooked cause of hyperkalemia.
Tan SY; Burton M
Arch Intern Med; 1981 Jan; 141(1):30-3. PubMed ID: 7004370
[TBL] [Abstract][Full Text] [Related]
6. Severe hyperkalaemia due to mefenamic acid-induced hyporeninaemic hypoaldosteronism.
Chan JC; Chan TY; Ko TC; Chow CC; Critchley JA
Br J Clin Pract; 1995; 49(3):161-2. PubMed ID: 7779674
[TBL] [Abstract][Full Text] [Related]
7. Hyperkalemia due to hyporeninemic hypoaldosteronism with liver cirrhosis and hypertension.
Kee CS; Choi JW; Chang DK; Ahn YH; Kim HJ
J Korean Med Sci; 1993 Dec; 8(6):464-70. PubMed ID: 8179835
[TBL] [Abstract][Full Text] [Related]
8. [21-hydroxylase deficit revealed by hyperkalemia in the absence of renal failure in an insulin-dependent diabetic (author's transl)].
Wechsler B; Colin JY; Raux-Eurin MG; Conessa JM; Godeau P
Ann Med Interne (Paris); 1981; 132(4):241-5. PubMed ID: 6975592
[TBL] [Abstract][Full Text] [Related]
9. Severe hyperkalaemia after cotrimoxazole administration in a patient with hyporeninaemic hypoaldosteronism.
Elisaf M; Terrovitou C; Tomos P; Siamopoulos KC
Nephrol Dial Transplant; 1997 Jun; 12(6):1254-5. PubMed ID: 9198062
[No Abstract] [Full Text] [Related]
10. Recurrent hyperkalaemia due to selective aldosterone deficiency: correction by angiotensin infusion.
Brown JJ; Chinn RH; Fraser R; Lever AF; Morton JJ; Robertson JI; Tree M; Waite MA; Park DM
Br Med J; 1973 Mar; 1(5854):650-4. PubMed ID: 4348186
[TBL] [Abstract][Full Text] [Related]
11. [Hyporeninemic hypoaldosteronism. Case report and attempt at pathophysiological classification (author's transl)].
Cuervas-Mons V; Moya Mir MS; Martín Martín F; Barbadillo García de Velasco R; Sánchez Miró I; Martín Jiménez T; Lorenz Pérez P
Med Clin (Barc); 1980 Nov; 75(8):342-5. PubMed ID: 7003270
[TBL] [Abstract][Full Text] [Related]
12. Hyperkalemia and hyporeninemic hypoaldosteronism.
DeFronzo RA
Kidney Int; 1980 Jan; 17(1):118-34. PubMed ID: 6990088
[No Abstract] [Full Text] [Related]
13. [Hyporeninemic hypoaldosteronism and the differential diagnosis of hyperkalemia].
Weidmann P
Schweiz Med Wochenschr; 1982 Dec; 112(49):1764-74. PubMed ID: 6758113
[TBL] [Abstract][Full Text] [Related]
14. [Hyporeninemic hypoaldosteronism with hyperpotassemia. Clinical and physiopathologic study of 18 cases].
Paladini G; Bertolini L; Picco S; Sgoifo E
Recenti Prog Med; 1983 Dec; 74(12):1370-84. PubMed ID: 6324306
[No Abstract] [Full Text] [Related]
15. Reversal of glucose-induced hyperkalemia by sodium restriction in "normaldosteronemic" diabetes mellitus.
Radó JP
Endokrinologie; 1981 Dec; 78(2-3):244-52. PubMed ID: 7037374
[TBL] [Abstract][Full Text] [Related]
16. Urinary prostaglandins (PGE2 and PGI2) in hyporeninaemic hypoaldosteronism in diabetic patients with chronic renal failure.
Gómez-Martino JR; Miralles JM; De Leon B; Hernandez MT; Tabernero JM
Nephrol Dial Transplant; 1994; 9(3):251-6. PubMed ID: 8052430
[TBL] [Abstract][Full Text] [Related]
17. Hyporeninaemic hypoaldosteronism after growth hormone treatment.
Mönig H; Peter M; Sippell WG
Lancet; 1996 Jan; 347(8994):119. PubMed ID: 8538313
[No Abstract] [Full Text] [Related]
18. Hyperkalaemia with cyclooxygenase-2 inhibition and hypoaldosteronism.
Lam Q; Schneider HG
Intern Med J; 2005 Sep; 35(9):572-3. PubMed ID: 16105165
[No Abstract] [Full Text] [Related]
19. Hyperkalaemia in a patient with Graves' disease.
Ng CW; Chan NN; So WY; Chan WB; Chow CC
Int J Clin Pract; 2003 Sep; 57(7):631-2. PubMed ID: 14529068
[TBL] [Abstract][Full Text] [Related]
20. [Risk for hyperkalemia during long-term treatment with angiotensin-converting enzyme inhibitors in insulin-dependent type 2 diabetics in relation to the glomerular filtration rate].
Raml A; Schmekal B; Grafinger P; Biesenbach G
Dtsch Med Wochenschr; 2001 Nov; 126(47):1327-30. PubMed ID: 11719857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
